BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Gut microbiota from green tea polyphenol-dosed mice improves intestinal epithelial homeostasis and ameliorates experimental colitis. ✅
Go to Publication ✅
Microbiome (Microbiome ) Vol: 9 Issue 1 Pages: 184 Pub: 2021 Sep 7 Epub: 2021 Sep 7 Authors Wu Z , Huang S , Li T , Li N , Han D , Zhang B , Xu ZZ , Zhang S , Pang J , Wang S , Zhang G , Zhao J , Wang J , |
|
|
Mechanisms of epigallocatechin gallate (EGCG) in ameliorating hyperuricemia: insights into gut microbiota and intestinal function in a mouse model. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 11 Pages: 6068-6081 Pub: 2024 Jun 4 Epub: 2024 Jun 4 Authors Yu H , Lou Z , Wu T , Wan X , Huang H , Wu Y , Li B , Tu Y , He P , Liu J , |
|
|
Epigallocatechin gallate alleviates osteoporosis by regulating the gut microbiota and serum metabolites in rats. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 23 Pages: 10564-10580 Pub: 2023 Nov 27 Epub: 2023 Nov 27 Authors Han X , Fu Y , Wang K , Li S , Jiang C , Wang S , Wang Z , Liu G , Hu S , |
|
|
Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 14 Pages: Pub: 2023 Jul 24 Epub: 2023 Jul 24 Authors de la Rubia Ortí JE , Moneti C , Serrano-Ballesteros P , Castellano G , Bayona-Babiloni R , Carriquí-Suárez AB , Motos-Muñoz M , Proaño B , Benlloch M , |
|
|
Epigallocatechin-3-Gallate Decreases Plasma and Urinary Levels of p-Cresol by Modulating Gut Microbiota in Mice. ✅
Go to Publication ✅
ACS omega (ACS Omega ) Vol: 7 Issue 44 Pages: 40034-40041 Pub: 2022 Nov 8 Epub: 2022 Oct 28 Authors Unno T , Ichitani M , |
|
|
Epigallocatechin-3-Gallate Decreases Plasma and Urinary Levels of p-Cresol by Modulating Gut Microbiota in Mice. ✅
Go to Publication ✅
ACS omega (ACS Omega ) Vol: 7 Issue 44 Pages: 40034-40041 Pub: 2022 Nov 8 Epub: 2022 Oct 28 Authors Unno T , Ichitani M , |
|
|
Dietary Epigallocatechin-3-Gallate Alters the Gut Microbiota of Obese Diabetic db/db Mice: Lactobacillus Is a Putative Target. ✅
Go to Publication ✅
Journal of medicinal food (J Med Food ) Vol: 23 Issue 10 Pages: 1033-1042 Pub: 2020 Oct Epub: Authors Park JM , Shin Y , Kim SH , Jin M , Choi JJ , |
|
|
Dietary Epigallocatechin-3-Gallate Alters the Gut Microbiota of Obese Diabetic db/db Mice: Lactobacillus Is a Putative Target. ✅
Go to Publication ✅
Journal of medicinal food (J Med Food ) Vol: 23 Issue 10 Pages: 1033-1042 Pub: 2020 Oct Epub: Authors Park JM , Shin Y , Kim SH , Jin M , Choi JJ , |
|
|
Reciprocal Interactions between Epigallocatechin-3-gallate (EGCG) and Human Gut Microbiota In Vitro. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 68 Issue 36 Pages: 9804-9815 Pub: 2020 Sep 9 Epub: 2020 Aug 26 Authors Liu Z , de Bruijn WJC , Bruins ME , Vincken JP , |
|
|
Reciprocal Interactions between Epigallocatechin-3-gallate (EGCG) and Human Gut Microbiota In Vitro. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 68 Issue 36 Pages: 9804-9815 Pub: 2020 Sep 9 Epub: 2020 Aug 26 Authors Liu Z , de Bruijn WJC , Bruins ME , Vincken JP , |
|
|
Effects of artificial honey and epigallocatechin-3-gallate on streptococcus pyogenes. ✅
Go to Publication ✅
BMC microbiology (BMC Microbiol ) Vol: 22 Issue 1 Pages: 207 Pub: 2022 Aug 26 Epub: 2022 Aug 26 Authors Jiang X , Lin A , Li S , Shi Y , Zhou F , Felix Gomez GG , Gregory RL , Zhang C , Chen S , Huang R , |
|
|
Combined use of epigallocatechin-3-gallate (EGCG) and caffeine in low doses exhibits marked anti-obesity synergy through regulation of gut microbiota and bile acid metabolism. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 12 Issue 9 Pages: 4105-4116 Pub: 2021 May 11 Epub: Authors Zhu MZ , Zhou F , Ouyang J , Wang QY , Li YL , Wu JL , Huang JA , Liu ZH , |
|
|
[Inhibitory effect of green tea polyphenols varnish on oral main cariogenic bacteria.]. ✅
Shanghai kou qiang yi xue = Shanghai journal of stomatology (Shanghai Kou Qiang Yi Xue ) Vol: 4 Issue 4 Pages: 198-200 Pub: 1995 Dec Epub: Authors Liu YL , Feng XP , Zhu M , |
|
|
Phytochemical characterization, and antioxidant and antibacterial activities of the hydroethanolic extract of Anadenanthera peregrina stem bark. ✅
Go to Publication ✅
Brazilian journal of biology = Revista brasleira de biologia (Braz J Biol ) Vol: 82 Issue Pages: e234476 Pub: 2021 Epub: 2021 Mar 5 Authors Marinho TA , Oliveira MG , Menezes-Filho ACP , Castro CFS , Oliveira IMM , Borges LL , Melo-Reis PR , Silva-Jr NJ , |
|
|
Antibacterial efficacy of epigallocatechin-3-gallate cross-linked small intestinal submucosa guided bone regeneration membrane. ✅
Go to Publication ✅
Dental materials journal (Dent Mater J ) Vol: 42 Issue 5 Pages: 624-632 Pub: 2023 Sep 29 Epub: 2023 Aug 23 Authors Gou M , Zou C , Jiang Y , Xie H , Wang H , Song H , |
|
|
Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: 16 Issue 1 Pages: 2392875 Pub: 2024 Jan-Dec Epub: 2024 Aug 25 Authors Jardon KM , Goossens GH , Most J , Galazzo G , Venema K , Penders J , Blaak EE , |
|
|
Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: 16 Issue 1 Pages: 2392875 Pub: 2024 Jan-Dec Epub: 2024 Aug 25 Authors Jardon KM , Goossens GH , Most J , Galazzo G , Venema K , Penders J , Blaak EE , |
|
|
Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: 16 Issue 1 Pages: 2392875 Pub: 2024 Jan-Dec Epub: 2024 Aug 25 Authors Jardon KM , Goossens GH , Most J , Galazzo G , Venema K , Penders J , Blaak EE , |
|
|
Epicatechin gallate and its analogues interact with sortase A and ß-lactamase to suppress Staphylococcus aureus virulence. ✅
Go to Publication ✅
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 15 Issue Pages: 1537564 Pub: 2025 Epub: 2025 Mar 25 Authors Teng F , Wang L , Wen J , Tian Z , Wang G , Peng L , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
